Glycemic control and pregnancy outcomes in patients with diabetes in pregnancy: A retrospective study

Indian J Endocrinol Metab. 2016 Jul-Aug;20(4):481-90. doi: 10.4103/2230-8210.183478.

Abstract

Context: Diabetes in pregnancy (DIP) is either pregestational or gestational.

Aims: To determine the relationship between glycemic control and pregnancy outcomes in a cohort of DIP patients.

Settings and design: In this 12-month retrospective study, a total of 325 Saudi women with DIP who attended the outpatient clinics at a tertiary center Riyadh, Saudi Arabia, were included.

Subjects and methods: The patients were divided into two groups, those with glycated hemoglobin (HbA1c) ≤6.5% (48 mmol/mol) and those with glycated hemoglobin (HbA1c) above 6.5%. The two groups were compared for differences in maternal and fetal outcomes.

Statistical analysis used: Independent Student's t-test and analysis of variance were performed for comparison of continuous variables and Chi-square test for frequencies. Odds ratio and 95% confidence intervals were calculated using logistic regression.

Results: Patients with higher HbA1c were older (P = 0.0077), had significantly higher blood pressure, proteinuria (P < 0.0001), and were multiparous (P = 0.0269). They had significantly shorter gestational periods (P = 0.0002), more preterm labor (P < 0.0001), more perineal tears (P = 0.0406), more miscarriages (P < 0.0001), and more operative deliveries (P < 0.0001). Their babies were significantly of greater weight, had more Neonatal Intensive Care Unit (NICU) admissions, hypoglycemia, and macrosomia.

Conclusions: Poor glycemic control during pregnancy is associated with adverse maternal and fetal outcomes (shortened gestational period, greater risk of miscarriage, increased likelihood of operative delivery, hypoglycemia, macrosomia, and increased NICU admission). Especially at risk are those with preexisting diabetes, who would benefit from earlier diabetes consultation and tighter glycemic control before conception.

Keywords: Diabetes in pregnancy; Type 1 diabetes; Type 2 diabetes; gestational diabetes; pregnancy adverse outcomes.